Four Vanderbilt technologies earned patent protection in January. These include:
8,635,940 - Solenoid Valve Assembly, developed by Michael Goldfarb and Xiangrong Shen in the Department of Mechanical Engineering and Physics and Astronomy, respectively;
8,632,988 - Pathogen hemoglobin receptor specificity for human hemoglobin, developed by Eric Skaar and Glib Pishchany in the Department of Pathology, Microbiology and Immunology;
8,623,555 - Electrode useable in electrochemical cell and method of making same, developed by Weng Poo Kang, Supil Raina, Shao-Hua Hsu, and SiYu Wei in the Department of Electical Engineering and Computer Science; and
8,623,098 - Systems and method for volitional control of jointed mechanical devices based on surface electromyography, developed by Michael Goldfarb, Huseyin Atakan Varol, and Kevin Ha in the Department of Mechanical Engineering.